Dual action treatment for aggressive breast cancer

Scientists at Israel’s Weizmann Institute have made a breakthrough in treating triple negative breast cancer. This cancer lacks three receptors that serve as targets for anti-cancer drugs. However, inhibiting molecules EGFR and PYK2 significantly reduces the size of tumors.

http://www.jewishpress.com/news/breaking-news/israeli-research-produces-new-hope-for-breast-cancer-patients/2017/01/01/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.